Skip to main content

Table 2 Table showing antibiotic susceptibility of Staphylococcus aureus isolates

From: Low prevalence of methicillin resistant Staphylococcus aureus as determined by an automated identification system in two private hospitals in Nairobi, Kenya: a cross sectional study

Antibiotic

Susceptible

Intermediate

Resistant

No. (%)

No. (%)

No. (%)

Penicillin

57 (7.8%)

0 (0.0%)

674 (92.2%)

Oxacillin

704 (96.3%)

0 (0.0%)

27 (3.7%)

Cefoxitin

707 (96.7%)

0 (0.0%)

24 (3.3%)

Erythromycin

645 (88.2%)

1 (0.1%)

85 (11.7%)

Clindamycina

658 (90.0%)

0 (0.0%)

73 (10.0%)

Gentamicin

710 (97.1%)

7 (1.0%)

14 (1.9%)

Tobramycin

708 (96.8%)

5 (0.7%)

18 (2.5%)

Levofloxacin

687 (94.0%)

31 (4.2%)

13 (1.8%)

Moxifloxacin

724 (99.1%)

1 (0.1%)

6 (0.8%)

Linezolid

731 (100.0%)

0 (0.0%)

0 (0.0%)

Mupirocin

731 (100.0%)

0 (0.0%)

0 (0.0%)

Rifampicin

725 (99.2%)

3 (0.4%)

3 (0.4%)

TMP/SMXb

423 (57.9%)

0 (0.0%)

308 (42.1%)

Tetracycline

618 (84.5%)

0 (0.0%)

113 (15.5%)

Tigecycline

731 (100.0%)

0 (0.0%)

0 (0.0%)

Teicoplanin

731 (100.0%)

0 (0.0%)

0 (0.0%)

Vancomycin

731 (100.0%)

0 (0.0%)

0 (0.0%)

  1. a59 isolates were susceptible to clindamycin based on MICs but were reported as resistant as they had inducible clindamycin resistance.
  2. bTMP/SMX-Trimethoprim/Sulfamethoxazole.